-
Dana-Farber faces scrutiny over research integrity
A combination of artificial intelligence and image screening software used by a blogger allegedly found evidence of data manipulation across a range of research papers published by four experts at the Dana-Farber Cancer Institute in Boston dating back to 1997. -
RWJBarnabas building 3 new cancer centers
West Orange, N.J.-based RWJBarnabas Health has three new cancer centers under construction, including New Jersey's first freestanding cancer center. -
Experts scramble to understand rising cancer rates in young adults
Cancer diagnosis rates among people under 50 are on the rise. In the U.S, the rate among this group jumped nearly 13% from 2000 — when it was 95.6 cases per 100,000 people — to 107.8 by 2019. Physicians and scientists are baffled, scrambling to determine what's beneath the surge and how to identify people at high risk, The Wall Street Journal reported Jan. 11. -
Medicaid expansion helps cancer patients access care: Study
An American Cancer Society study found states with expanded Medicaid status had more insurance coverage for newly diagnosed cancer patients and fewer uninsured patients. -
Largest trial to study prevention of heart failure in childhood cancer survivors concludes
City of Hope and Children's Oncology Group researchers conducted the largest clinical trial to date to investigate the prevention of childhood cancer survivors from developing heart failure. -
Cancer groups address 'urgent threat' to cancer treatment
Four groups are asking policymakers to address the "urgent threat facing cancer treatment access" by changing Medicare payments. -
Zika could treat rare tumors: Study
Jacksonville, Fla.-based Nemours Children's Health researchers found the Zika virus could be used to shrink neuroblastoma tumors. -
Dana-Farber pitches $1.68B cancer hospital
Boston-based Dana-Farber Cancer Institute recently made its first official pitch to Massachusetts regulators about its $1.68 billion proposal to establish a standalone cancer hospital in partnership with Beth Israel Deaconess Medical Center, The Boston Globe reported Jan. 8. -
MUSC Hollings Cancer Center appoints inaugural deputy director
Charleston, S.C.-based MUSC Hollings Cancer Center has named William Hawkins, MD, as its inaugural deputy director, according to a Jan. 3 news release. -
Mayo Clinic plans $9M cancer center expansion
Mayo Clinic is launching a $9 million expansion and renovation to its New Prague cancer center beginning in 2024. -
3 stats on prior authorization's effect on cancer care
Most private and federal health insurance programs require prior authorization for certain treatments in order to reduce spending and avoid unnecessary care; however, the process may increasingly prevent patients from receiving the right care when they need it, The Lund Report reported Jan. 2. -
Fred Hutch hit with 9 lawsuits after cyberattack
Seattle-based Fred Hutchinson Cancer Center is facing nine lawsuits after a cyberattack leaked clinical data in November. -
Piedmont formalizes oncology treatment center
Atlanta-based Piedmont health system has announced the formation of a program to improve access for cancer patients to "promising" cell, gene and immunotherapies as well as detection strategies, according to a Jan. 2 news release shared with Becker's. -
FDA places clinical hold on lung cancer trial after patient death
The death of a study participant has prompted the FDA to place a clinical hold on an Iovance Biotherapeutics trial, the company said Dec. 22. -
Mammograms are coming to Walmart
Walmart has partnered with RadNet to offer its first pilot mammogram program in a store in Milford, Del. -
Where oncology needs the most change
A recent Becker's poll found treatment options were voted the area most in need of change in cancer care. -
123 cancer centers opening, expanding, affiliating in 2023
Here are 123 cancer centers opening, expanding or affiliating: -
107 oncologists on the move
Here are 107 oncologists starting new roles: -
Northwestern expands cancer center with $51M gift
The Northwestern Medicine St. George Cancer Institute opened its expanded services thanks to a $51 million gift, the Chicago Tribune reported Dec. 20. -
Study challenges 'gold standard' of cancer opioid treatment
Morphine is widely considered the "gold-standard treatment" for pain during cancer care, but a new study found the drug was not superior to other opiates.
Page 12 of 50